Does CENEGERMIN-BKBJ Cause Therapy partial responder? 113 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Therapy partial responder have been filed in association with CENEGERMIN-BKBJ. This represents 1.0% of all adverse event reports for CENEGERMIN-BKBJ.
113
Reports of Therapy partial responder with CENEGERMIN-BKBJ
1.0%
of all CENEGERMIN-BKBJ reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapy partial responder From CENEGERMIN-BKBJ?
Of the 113 reports, 2 (1.8%) required hospitalization.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CENEGERMIN-BKBJ. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does CENEGERMIN-BKBJ Cause?
Eye pain (5,847)
Eye irritation (1,871)
Product dose omission issue (1,335)
Ocular hyperaemia (1,226)
Photophobia (1,065)
Vision blurred (944)
Wrong technique in product usage process (899)
Eye swelling (847)
Ocular discomfort (797)
Lacrimation increased (737)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which CENEGERMIN-BKBJ Alternatives Have Lower Therapy partial responder Risk?
CENEGERMIN-BKBJ vs CENOBAMATE
CENEGERMIN-BKBJ vs CEPHALEXIN
CENEGERMIN-BKBJ vs CERITINIB
CENEGERMIN-BKBJ vs CERLIPONASE ALFA
CENEGERMIN-BKBJ vs CERTICAN